Inogatran (INN) is a low molecular weight peptidomimetic thrombin inhibitor. Inogatran was developed for the potential treatment of arterial and venous thrombotic diseases.
{{chembox | ImageFile = Inogatran.svg | ImageClass = skin-invert-image | ImageSize = 275px | ImageAlt = | IUPACName = 2-{[(2R)-1-[(2S)-2-[(4-Carbamimidamidopropyl)carbamoyl]piperidin-1-yl]-3-cyclohexyl-1-oxopropan-2-yl]amino}acetic acid | OtherNames = N-[(1R)-2-Cyclohexyl-1-[[(2S)-2-[(3-guanidinopropyl)carbamoyl]piperidino]carbonyl]ethyl]glycine
| Section1 =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).